Clovis Oncology reported $621.38M in Loan Capital for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Agios Pharmaceuticals AGIO:US USD 1.06M 0
Arrowhead Research ARWR:US USD 0 0
Astrazeneca AZN:US USD 23.68B 3.47B
AstraZeneca AZN:LN USD 23.68B 3.47B
Eli Lilly And LLY:US USD 14.14B 548.2M
Enanta Pharmaceuticals ENTA:US USD 1.42M 83K
Esperion Therapeutics ESPR:US USD 259.49M 407K
GlaxoSmithKline GSK:LN GBP 19.32B 538M
Halozyme Therapeutics HALO:US USD 1.49B 344.03M
Insmed INSM:US USD 807.48M 366K
Novartis NOVN:VX USD 21.24B 2.55B
Veracyte VCYT:US USD 500K 100K